Drug-induced aseptic meningitis

Expert Opinion on Drug Safety

Volumn 4, Issue 2, 2005, Pages 285-297

  Hopkins, Susan ^a   Jolles, Stephen ^a,b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Antibiotics; Aseptic meningitis; Drug induced aseptic meningitis; Immunomodulator; Intravenous immunoglobulin; Non steroidal anti inflammatory drug (NSAID)

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; ALLOPURINOL; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZATHIOPRINE; BACLOFEN; BUPIVACAINE; CARBAMAZEPINE; CEFTAZIDIME; CELECOXIB; CEPHALOSPORIN; CIPROFLOXACIN; CYCLOOXYGENASE 2 INHIBITOR; CYTARABINE; CYTOSINE; DEXCHLORPHENIRAMINE; DEXIBUPROFEN; DICLOFENAC; DYE; FAMOTIDINE; GENTAMICIN; GRISEOFULVIN; IBUPROFEN; IMMUNOGLOBULIN; INFLIXIMAB; INTERLEUKIN 6; IODINATED CONTRAST MEDIUM; IOHEXOL; IOPAMIDOL; IOTROLAN; ISONIAZID; KETOPROFEN; LEFLUNOMIDE; MACROGOL; MEASLES VACCINE; MEGLUMINE IOCARMATE; METHOTREXATE; METRIZAMIDE; METRONIDAZOLE; MONOCLONAL ANTIBODY; MUMPS VACCINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OKT 3; ORNIDAZOLE; PENICILLIN G; PENTOXIFYLLINE; PHENAZOPYRIDINE; PIROXICAM; PLACEBO; PYRAZINAMIDE; RANITIDINE; ROFECOXIB; RUBELLA VACCINE; SALAZOSULFAPYRIDINE; STEROID; SULFAMETHIZOLE; SULINDAC; TOLMETIN; TRIMETHOPRIM; VACCINE; VALACICLOVIR; VINCRISTINE;

ALOPECIA; ANTIBODY PRODUCTION; ASEPTIC MENINGITIS; AUTOIMMUNE DISEASE; BRAIN ISCHEMIA; CEREBELLAR ATAXIA; CEREBROSPINAL FLUID CULTURE; CLINICAL FEATURE; CLINICAL TRIAL; CONFUSION; CONNECTIVE TISSUE DISEASE; CONSCIOUSNESS DISORDER; CRANIAL NERVE PARALYSIS; CROSS REACTION; CYSTIC FIBROSIS; DESQUAMATION; DISEASE ACTIVITY; DISEASE COURSE; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG SENSITIVITY; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; FACE EDEMA; FEVER; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE COMPLEX DEPOSITION; IMMUNOGLOBULIN PRODUCTION; INCIDENCE; INFLAMMATION; LIPOPHILICITY; LYMPHADENOPATHY; MEDLINE; META ANALYSIS; MIGRAINE; MOLECULAR SIZE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PERIPHERAL NEUROPATHY; PH; PLEOCYTOSIS; PROBABILITY; PROTEIN CEREBROSPINAL FLUID LEVEL; RAYNAUD PHENOMENON; REVIEW; SEIZURE; SEX RATIO; SOMNOLENCE; SYSTEMATIC REVIEW; THORAX PAIN; VESTIBULAR DISORDER;

ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLORING AGENTS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INJECTIONS, SPINAL; MENINGITIS, ASEPTIC; MUROMONAB-CD3; VACCINES;

EID: 20944444110     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.4.2.285     Document Type: Review

References (216)

1. DAVISON SP, MARION MS: Sensorineural hearing loss caused by NSAID-induced aseptic meningitis. Ear Nose Throat J. (1998) 77:820-826.
2. AGUS B, NELSON J, KRAMER N, MAHAL SS, ROSENSTEIN ED: Acute central nervous system symptoms caused by ibuprofen in connective tissue disease. J. Rheumatol. (1990) 17:1094-1096.
3. JENSEN S, GLUD TK, BACHER T, ERSGAARD H: Ibuprofen-induced meningitis in a male with systemic lupus erythematosus. Acta Med. Scand. (1987) 221:509-511.
4. HARRISON MS, SIMONTE SJ, KAUFFMAN CA: Trimethoprim-induced aseptic meningitis in a patient with AIDS: case report and review. Clin. Infect. Dis. (1994) 19:431-434.
5. DAVIS BJ, THOMPSON J, PEIMANN A, BENDIXEN BH: Drug-induced aseptic meningitis caused by two medications. Neurology (1994) 44:984-985.
6. DERBES SJ: Trimethoprim-induced aseptic meningitis. JAMA (1984) 252:2865-2866.
7. HEDLUND J, AURELIUS E, ANDERSSON J: Recurrent encephalitis due to trimethoprim intake. Scand. J. Infect. Dis. (1990) 22:109-112.
8. BLUMENFELD H, CHA JH, CUDKOWICZ ME: Trimethoprim and sulfonamide-associated meningoencephalitis with MRI correlates. Neurology (1996) 46:556-558.
9. CAPONE PM, COHEN ME: Seizures and cerebritis associated with administration of OKT 3. Pediatr. Neurol. (1991) 7:299-301.
10. EUSTACE S, BUFF B: Magnetic resonance imaging in drug-induced meningitis. Can. Assoc. Radiol. J. (1994) 45:463-465.
11. OBERMOSER G, BELLMANN R, PFAUSLER B, SCHMUTZHARD E, SEPP N: Aseptic meningo-encephalitis related to dexibuprofen use in a patient with systemic lupus erythematosus: a case report with MR findings. Lupus (2002) 11:451-453.
12. CAPRA C, MONZA GM, MEAZZA G, RAMELLA G: Trimethoprim-sulfamethoxazole-induced aseptic meningitis: case report and literature review. Intensive Care Med. (2000) 26:212-214.
13. GARAGUSI VF, NEEFE LI, MANN O: Acute meningoencephalitis: Association with isoniazid administration. JAMA (1976) 235:1141-1142.
14. LORTHOLARY A, VARACHE N, BOUACHOUR G, SZAPIRO N, BOURRIER P, ALQUIER P: Generalized status epilepticus after ingestion of ibuprofen (Brufen), disclosing systemic lupus erythematosus. Rev. Med. Interne (1990) 11:243-244.
15. PATEY O, LACHEHEB A, DELLION S, ZANDITENAS D, JUNGFER-BOUVIER F, LAFAIX C: A rare case of cotrimoxazole-induced eosinophilic aseptic meningitis in an HIV-infected patient. Scand. J. Infect. Dis. (1998) 30:530-531.
16. PERERA DR, SEIFFERT AK, GREELEY HM: Ibuprofen and meningoencephalitis. Ann. Intern. Med. (1984) 100:619.
17. MALLAT Z, VASSAL T, NAOURI JF, PRIER A, LAREDO JD, OFFENSTADT G: Aseptic meningoencephalitis after iopamidol myelography. Lancet (1991) 338:252.
18. JOLLES S, SEWELL WA, LEIGHTON C: Drug-induced aseptic meningitis: diagnosis and management. Drug Saf. (2000) 22:215-226.
19. BROUNS R, CROLS R, ENGELBORGHS S, DE DEYN PP: Pituitary apoplexy presenting as chemical meningitis. Lancet (2004) 364:502.
20. CARMEL PW, GREIF LK: The aseptic meningitis syndrome: a complication of posterior fossa surgery. Pediatr. Neurosurg. (1993) 19:276-280.
21. BENNETT RA, HARBILAS E: Wilson's disease with aseptic meningitis and penicillamine-related cheilosis. Arch. Intern. Med. (1967) 120:374-376.
22. AUSTIN DA, SOKOLOWSKI JW, JR: Postlumbar puncture chemical meningitis. N Y State J. Med. (1968) 68:2444-2446.
23. ENG RH, SELIGMAN SJ: Lumbar puncture-induced meningitis. JAMA (1981) 245:1456-1459.
24. NO AUTHORS LISTED: Principles and Practice of Infectious Diseases: Churchill Livingstone, 2000.
25. HOFFMAN M, GRAY RG: Ibuprofen-induced meningitis in mixed connective tissue disease. Clin. Rheumatol. (1982) 1:128-130.
26. BALLAS ZK, DONTA ST: Sulindac-induced aseptic meningitis. Arch. Intern. Med. (1982) 142:165-166.
27. RUPPERT GB, BARTH WF: Tolmetin-induced aseptic meningitis. JAMA (1981) 245:67-68.
28. RIVER Y, AVERBUCH-HELLER L, WEINBERGER M et al.: Antibiotic induced meningitis. J. Neurol. Neurosurg. Psychiatry (1994) 57:705-708.
29. MORIS G, GARCIA-MONCO JC: The challenge of drug-induced aseptic meningitis. Arch. Intern. Med. (1999) 159:1185-1194.
30. SEKUL FA, CUPLER EJ, DALAKAS MC: Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann. Intern. Med. (1994) 121:259-262.
31. WIDENER HL, LITTMAN BH: Ibuprofen-induced meningitis in systemic lupus erythematosus. JAMA (1978) 239:1062-1064.
32. ASHWATH ML, KATNER HP: Recurrent aseptic meningitis due to different non-steroidal anti-inflammatory drugs including rofecoxib. Postgrad. Med. J. (2003) 79:295-296.
33. NGUYEN HT, JUURLINK DN: Recurrent ibuprofen-induced aseptic meningitis. Ann. Pharmacother. (2004) 38:408-410.
34. BONNEL RA, VILLALBA ML, KARWOSKI CB, BEITZ J: Aseptic meningitis associated with rofecoxib. Arch. Intern. Med. (2002) 162:713-715.
35. PISANI E, FATTORELLO C, LEOTTA MR, MARCELLO O, ZULIANI C: Recurrence of ibuprofen-induced aseptic meningitis in an otherwise healthy patient. Ital. J. Neurol. Sci. (1999) 20:59-62.
36. SEATON RA, FRANCE AJ: Recurrent aseptic meningitis following non- steroidal anti-inflammatory drugs-a reminder. Postgrad. Med. J. (1999) 75:771-772.
37. WEKSLER BB, LEHANY AM: Naproxen-induced recurrent aseptic meningitis. DICP (1991) 25:1183-1184.
38. MIFSUD AJ: Drug-relared recurrent meningitis. J. Infect. (1988) 17:151-153.
39. VON REYN CF: Recurrent aseptic meningitis due to sulindac. Ann. Intern. Med. (1983) 99:343-344.
40. TREVES R, GASTINE H, RICHARD A et al.: Aseptic meningitis and acute renal failure induced by ibuprofen during the treatment of systemic lupus erythematosus. Rev. Rhum. Mal. Osteoartic. (1983) 50:75-76.
41. SAMUELSON CO JR, WILLIAMS HJ: Ibuprofen-associated aseptic meningitis in systemic lupus erythematosus. West J. Med. (1979) 131:57-59.
42. WASNER CK: Ibuprofen, meningitis, and systemic lupus erythematosus. J. Rheumatol. (1978) 5:162-164.
43. CHEZ M, SILA CA, RANSOHOFF RM, LONGWORTH DL, WEIDA C: Ibuprofen-induced meningitis: detection of intrathecal IgG synthesis and immune complexes. Neurology (1989) 39:1578-1580.
44. EWERT BH: Ibuprofen-associated meningitis in a woman with only serologic evidence of a rheumatologic disorder. Am. J. Med. Sci (1989) 297:326-327.
45. GREENBERG GN: Recurrent sulindac-induced aseptic meningitis in a patient tolerant to other nonsteroidal anti-inflammatory drugs. South. Med. J. (1988) 81:1463-1464.
46. DURBACK MA, FREEMAN J, SCHUMACHER VR, JR: Recurrent ibuprofen-induced aseptic meningitis: third episode after only 200 mg of generic ibuprofen. Arthritis Rheum. (1988) 31:813-815.
47. BOULAND DL, SPECHT NL, HEGSTAD DR: Ibuprofen and aseptic meningitis. Ann. Intern. Med. (1986) 104:731.
48. FINCH WR, STROTTMAN MP: Acute adverse reactions to ibuprofen in systemic lupus erythematosus. JAMA (1979) 241:2616-2618.
49. SONNENBLICK M, ABRAHAM AS: Ibuprofen hypersensitivity in systemic lupus erythematosus. Br. Med. J. (1978) 1:619-620.
50. LORINO GD, HARDIN JG, JR: Sulindac-induced meningitis in mixed connective tissue disease. South. Med. J. (1983) 76:1185-1187.
51. VAN DER ZWAN A, VAN DEM JG: Ibuprofen meningitis. Ned. Tijdschr. Geneeskd (1992) 136:1613-1614.
52. CODDING C, TARGOFF IN, MCCARTY GA: Aseptic meningitis in association with diclofenac treatment in a patient with systemic lupus erythematosus. Arthritis Rheum. (1991) 34:1340-1341.
53. BERLINER S, WEINBERGER A, SHOENFELD Y et al.: Ibuprofen may induce meningitis in (NZB × NZW)F1 mice. Arthritis Rheum. (1985) 28:104-107.
54. SHOENFELD Y, LIVNI E, SHAKLAI M, PINKHAS J: Sensitization to ibuprofen in systemic lupus erythematosus. JAMA (1980) 244:547-548.
55. BARRETT P, THIER S: Meningitis and pancreatitis associated with sulfamethizole. N. Engl. J. Med. (1963) 268:36-37.
56. THAUNAT O, GILQUIN J, LAZARETH I, PRIOLLET P: Amoxicillin-induced aseptic meningo-encephalitis. Allergy (2003) 58:687-688.
57. KASTENBAUER S, PFISTER HW, WICK M: No evidence of Type 1 or Type 3 hypersensitivity mechanism in amoxicillin/clavulanic acid induced aseptic meningitis J. Neurol. Neurosurg. Psychiatry (2003) 74:690-691.
58. FARMER L, ECHLIN FA, LOUGHLIN WC, BREAKEY AS, DUVOISIN R: Pachymeningitis apparently due to penicillin hypersensitivity. Ann. Intern. Med. (1960) 52:910-914.
59. WITTMANN A, WOOTEN GF: Amoxicillin-induced aseptic meningitis. Neurology (2001) 57:1734.
60. CZERWENKA W, GRUENWALD C, CONEN D: Aseptic meningitis after treatment with amoxicillin. Br. Med. J. (1999) 318:1521.
61. JACOBSSON G, ELOWSON S: Amoxicillin caused aseptic meningoencephalitis. Lakartidningen (1999) 96:201-202.
62. MATEOS V, CALLEJA S, JIMENEZ L, SUAREZ-MORO R: Recurrent aseptic meningitis associated with amoxicillin-clavulanic acid. Med. Clin. (Barc) (2000) 114:79.
63. EHSAN T, MALKOFF MD: Acute isoniazid poisoning simulating meningoencephalitis. Neurology (1995) 45:1627-1628.
64. FOBELO MJ, CORZO DELGADO JE, ROMERO AA, GOMEZ-BELLVER MJ: Aseptic meningitis related to valacyclovir. Ann. Pharmacother. (2001) 35:128-129.
65. OLIN JL, GUGLIOTTA JL: Possible valacyclovir-related neurotoxicity and aseptic meningitis. Ann. Pharmacother. (2003) 37:1814-1817.
66. KISHIYAMA JL, VALACER D, CUNNINGHAM-RUNDLES C et al.: A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin. Immunol. (1999) 91:126-133.
67. SCHIAVOTTO C, RUGGERI M, RODEGHIERO F: Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Haematologica (1993) 78:35-40.
68. OZSOYLU S: Aseptic meningitis and intravenous gammaglobulin treatment. Am. J. Dis. Child (1993) 147:129-130.
69. MSELATI JC, CARLIER JC, ROUTON MC, NOUI MF, DE GENNES C: [Intravenous immunoglobulins and aseptic meningitis]. Arch. Fr. Pediatr. (1992) 49:216.
70. OBANDO I, DURAN I, MARTIN-ROSA L, CANO JM, GARCIA-MARTIN FJ: Aseptic meningitis due to administration of intravenous immunoglobulin with an unusually high number of leukocytes in cerebrospinal fluid. Pediatr. Emerg. Care (2002) 18:429-432.
71. KATO T, SUZUKI E, SONE M, YOSHIDA E, HIRAYAMA M: A case of recurrent aseptic meningitis caused by high-dose intravenous gammaglobulin therapy for chronic inflammatory demyelinating polyneuropathy. Rinsho Shinkeigaku (2001) 41:797-800.
72. JOLLES S, HILL H: Management of aseptic meningitis secondary to intravenous immunoglobulin. Br. Med. J. (1998) 316:936.
73. LAFFERTY TE, DEHORATIUS RJ, SMITH JB: Aseptic meningitis as a side effect of intravenous immune gammaglobulin. J. Rheumatol. (1997). 24:2491-2492.
74. PICTON P, CHISHOLM M: Aseptic meningitis associated with high dose immunoglobulin: case report. Br. Med. J. (1997) 315:1203-1204.
75. PREMINGER-SHAPIRO R, NUSSINOVITCH M, SOEN G, VARSANO I: Aseptic meningitis: a frequent side-effect of intravenous immunoglobulin? Eur. J. Pediatr. (1995) 154:866-867.
76. ELLIS RJ, SWENDSON MR, BAJOREK J: Aseptic meningitis as a complication of intravenous immunoglobulin therapy for myasthenia gravis. Muscle Nerve (1994) 17:683-684.
77. DE VLIEGHERE FC, PEETERMANS WE, VERMYLEN J: Aseptic granulocytic meningitis following treatment with intravenous immunoglobulin. Clin. Infect. Dis. (1994) 18:1008-1010.
78. MISBAH SA, CHAPEL HM: Adverse effects of intravenous immunoglobulin. Drug Saf. (1993) 9:254-262.
79. MITTERER M, PESCOSTA N, VOGETSEDER W, MAIR M, COSER P: Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura. Ann. Hematol. (1993) 67:151-152.
80. CASTEELS-VAN DAELE M, WIJNDAELE L, BROCK P, KRUGER M, GILLIS P: Aseptic meningitis associated with high dose intravenous immunoglobulin therapy. J. Neurol. Neurosurg. Psychiatry (1992) 55:980-981.
81. MOLINA JM, COFFINEAU A, RAIN JD, LETONTURIER D, MODAI J: Aseptic meningitis following administration of intravenous immune globulin. Clin. Infect. Dis. (1992) 15:564-565.
82. VERA-RAMIREZ M, CHARLET M, PARRY GJ: Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. Neurology (1992) 42:1636-1637.
83. PALLARES DE, MARSHALL GS: Acute aseptic meningitis associated with administration of intravenous immune globulin. Am J. Pediatr. Hematol. Oncol. (1992) 14:279.
84. RAO SP, TEITLEBAUM J, MILLER ST: Intravenous immune globulin and aseptic meningitis. Am. J. Dis. Child (1992) 146:539-540.
85. WATSON JD, GIBSON J, JOSHUA DE, KRONENBERG H: Aseptic meningitis associated with high dose intravenous immunoglobulin therapy. J. Neurol. Neurosurg. Psychiatry (1991) 54:275-276.
86. CASTEELS-VAN DAELE M, WIJNDAELE L, HANNINCK K, GILLIS P: Intravenous immune globulin and acute aseptic meningitis. N. Engl. J. Med. (1990) 323:614-615.
87. KRESSEBUCH H, SCHAAD UB, HIRTA, BIANCHETTI MG: Cerebrospinal fluid inflammation induced by intravenous immunoglobulins. Pediatr. Infect. Dis. J. (1992) 11:894-895.
88. KATTAMIS AC, SHANKAR S, COHEN AR: Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G. J. Pediatr. (1997) 130:281-283.
89. MEINER Z, BEN HUR T, RIVER Y, RECHES A: Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis. J. Neurol. Neurosurg. Psychiatry (1993) 56:830-831.
90. NEWLAND AC, BURTON I, CAVENAGH JD ET AL.: Vigam-S, a solvent/detergent-treated intravenous immunoglobulin, in idiopathic thrombocytopenic purpura. Transfus. Med. (2001) 11:37-44.
91. BALFOUR-LYNN IM, MOHAN U, BUSH A, ROSENTHAL M: Intravenous immunoglobulin for cystic fibrosis lung disease: a case series of 16 children. Arch. Dis. Child. (2004) 89:315-319.
92. SHORR AF, KESTER KE: Meningitis and hepatitis complicating intravenous immunoglobulin therapy. Ann. Pharmacother. (1996) 30:1115-1116.
93. YAMAZAKI M, MIZUTANI T, KATO M et al.: Aseptic meningitis induced by high-dose gamma-globulin in an adult woman with antiphospholipid syndrome and chronic idiopathic thrombocytopenic purpura. Rinsho Ketsueki (1999) 40:1110-1115.
94. EMMONS C, SMITH J, FLANIGAN M: Cerebrospinal fluid inflammation during OKT3 therapy. Lancet (1986) 2:510-511.
95. RODEN J, KLINTMALM GB, HUSBERG BS, NERY J, OLSON LM: Cerebrospinal fluid inflammation during OKT3 therapy. Lancet (1987) 2:272.
96. JOY ME, MICHALS ML, CANAFAX DM: Aseptic meningitis associated with muromonab-CD3 therapy. Clin. Pharm. (1988) 7:721.
97. MARTIN MA, MASSANARI RM, NGHIEM DD, SMITH JL, CORRY RJ: Nosocomial aseptic meningitis associated with administration of OKT3. JAMA (1988) 259:2002-2005.
98. THISTLETHWAITE JR, STUART JK, MAYES JT et al.: Complications and monitoring of OKT3 therapy. Am. J. Kidney Dis. (1988) 11:112-119.
99. PAAP CM: Comment: muromonab CD3 aseptic meningitis. DICP (1989) 23:716-717.
100. SUTTON JD, PRIOLEAU MH, WORDELL CJ, FRANCOS GC: Aseptic meningitis associated with muromonab CD3 administration. DICP (1989) 23:257-258.
101. RELLO J, VALLVERDU I, COLL P, GURGUI M, NET A: Aseptic meningitis associated with muromonab-CD3. DICP (1990) 24:1233.
102. ADAIR JC, WOODLEY SL, O'CONNELL JB, CALL GK, BARINGER JR: Aseptic meningitis following cardiac transplantation: clinical characteristics and relationship to immunosuppressive regimen. Neurology (1991) 41:249-252.
103. DREES C, HALEY CJ: Aseptic meningitis and muromonab-CD3 therapy. DICP (1991) 25:138-139.
104. URIBE ROCA MC, ZURRU MC, GATTO EM, MAGGIORA EC, AGOST CC, LUCIANO M: Aseptic meningitis due to OKT3. Neurologia (1998) 13:98-99.
105. THOMAS MC, WALKER R, WRIGHT A: HaNDL syndrome after 'benign' OKT3-induced meningitis. Transplantation (1999) 67:1384-1385.
106. FIGG WD: Aseptic meningitis associated with muromonab-CD3. DICP (1991) 25:1395.
107. SERGENT JS, LOCKSHIN MD, KLEMPNER MS, LIPSKY BA: Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis. Am. J. Med. (1975) 58:644-654.
108. MERRIN P, WILLIAMS IA: Meningitis associated with sulphasalazine in a patient with Sjogren's syndrome and polyarthritis. Ann. Rheum. Dis. (1991) 50:645-646.
109. COHEN JD, JORGENSEN C, SANY J: Leflunomide-induced aseptic meningitis. Joint Bone Spine (2004) 71:243-245.
110. MAROTTE H, CHARRIN JE, MIOSSEC P: Infliximab-induced aseptic meningitis. Lancet (2001) 358:1784.
111. MILLER E, GOLDACRE M, PUGH S et al.: Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children. Lancet (1993) 341:979-982.
112. DA CUNHA SS, RODRIGUES LC, BARRETO ML, DOURADO I: Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain. Vaccine (2002) 20:1106-1112.
113. DA SILVEIRA CM, KMETZSCH CI, MOHRDIECK R, SPERB AF, PREVOTS DR: The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997. Int. J. Epidemiol. (2002) 31:978-982.
114. BAESSLER B, LAHL R: Complications following myelography with positive contrast media (Pantopaque, Amipaque). Pathomorphologic findings in 2 fatal cases. Zentralbl. Neurochir. (1985) 46:141-150.
115. BO SH, NESTVOLD K, SORTLAND O: Meningitis after myelography. Tidsskr. Nor. Laegeforen. (1995) 115:2646-2647.
116. CISSOKO H, LEMESLE F, JONVILLE-BERA AP, AUTRET-LECA E: Aseptic meningitis after iohexol myelography. Ann. Pharmacother. (2000) 34:812-813.
117. HADDEN WA: Early meningitis side effects following lumbar radiculography with meglumine iocarmate. J. R. Coll. Surg. Edinb. (1982) 27:42-45.
118. HAMMER B: Acute meningeal reaction due to water-soluble contrast media. Wien. Med. Wochenschr. (1976) 126:373-375.
119. HANSEN EB, FAHRENKRUG A, PRAESTHOLM J: Late meningeal effects of myelographic contrast media with special reference to metrizamide. Br. J. Radiol. (1978) 51:321-327.
120. HAUGHTON VM: Intrathecal toxicity of iohexol versus metrizamide. Survey and current state. Invest. Radiol. (1985) 20:S14-S17.
121. HOEFFEL C, GAUCHER H, CHEVROT A, HOEFFEL JC: Complications of lumbar puncture with injection of hydrosoluble material. J. Spinal Disord. (1999) 12:168-171.
122. KALLIO M, SOMER H, VALTONEN V, KATEVUO K: Meningitis following myelography. Duodecim (1984) 100:1183-1187.
123. MCCORMICK CC, APSIMON HT, CHAKERA TM: Myelography with metrizamide-an analysis of the complications encountered in cervical, thoracic and lumbar myelography. Aust. NZ. J. Med. (1981) 11:645-650.
124. NAKAKOSHI T, MORIWAKA F, TASHIRO K, NAKANE K, MIYASAKA K: Aseptic meningitis complicating iotrolan myelography. AJNR Am. J. Neuroradiol. (1991) 12:173.
125. PEEK RD, THOMAS JC JR WILTSE LL: Diagnosis of lumbar arachnoiditis by myeloscopy. Spine (1993) 18:2286-2289.
126. SKUTTA T, VOGELSANG H, GALANSKI M, HAMMER B, WEINMANN HJ: Clinical trial of iotrol for lumbar myelography. AJNR Am. J. Neuroradiol. (1983) 4:302-303.
127. SPENCER CP, CHRISMAN CL, MAYHEW IG, KAUDE JV: Neurotoxicologic effects of the nonionic contrast agent iopamidol on the leptomeninges of the dog. Am. J. Vet. Res. (1982) 43:1958-1962.
128. WHITE WB: Metrizamide meningitis. South. Med. J. (1984) 77:88-89.
129. ABRAM SE, O'CONNOR TC: Complications associated with epidural steroid injections. Reg. Anesth. (1996) 21:149-162.
130. DEVOIZE JL, FUZEAU C, PIN JC, BONNEFOY M: Chemical meningitis after intradural injection of corticosteroids. Recovery without antibiotics. Presse Med. (1993) 22:879.
131. GUTKNECHT DR: Chemical meningitis following epidural injections of corticosteroids. Am. J. Med. (1987) 82:570.
132. MARINANGELI F, CICCOZZI A, DONATELLI F, PALADINI A, VARRASSI G: Clinical use of spinal or epidural steroids. Minerva Anestesiol. (2002) 68:613-620.
133. PLUMB VJ, DISMUKES WE: Chemical meningitis related to intrathecal corticosteroid therapy. South. Med. J. (1977) 70:1241-1243.
134. CHAUVET E, MOINEUSE C, NAVAUX F et al.: Pseudo-septic meningeal reaction after intradural glucocorticoid therapy for sciatica. Joint Bone Spine (2002) 69:95-96.
135. SHAPIRO WR, YOUNG DF: Neurological complications of antineoplastic therapy. Acta Neurol. Scand. Suppl. (1984) 100:125-132.
136. PEASE CL, HORTON TM, MCCLAIN KL, KAPLAN SL: Aseptic meningitis in a child after systemic treatment with high dose cytarabine. Pediatr. Infect. Dis. J. (2001) 20:87-89.
137. THORDARSON H, TALSTAD I: Acute meningitis and cerebellar dysfunction complicating high-dose cytosine arabinoside therapy. Acta Med. Scand. (1986) 220:493-495.
138. VAN DEN BERG H, VAN DER FLIER M, VAN DE WETERING MD: Cytarabine-induced aseptic meningitis. Leukemia (2001) 15:697-699.
139. CHAMBERLAIN MC, KORMANIK PA, BARBA D: Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. J. Neurosurg. (1997) 87:694-699.
140. CHAUDHRY VP, MARWA RK: Intrathecal methotrexate induced meningitis. Indian Pediatr. (1979) 16:87-89.
141. OBWEGESER A, SEIWALD M, STOCKHAMMER G: Intraventricular chemotherapy. J. Neurosurg. (1998) 89:172-173.
142. ELIAS DJ, KLINE LE, ROBBINS BA et al.: Monoclonal antibody KS1/4-methotrexate immunoconjugate studies in non-small cell lung carcinoma. Am. J. Respir. Crit. Care Med. (1994) 150:1114-1122.
143. MATHIAN A, AMOURA Z, PIETTE JC: Pentoxifylline-induced aseptic meningitis in a patient with mixed connective tissue disease. Neurology (2002) 59:1468-1469.
144. WAHID ST, BILOUS RW, ILIC D, NEWMAN P: Meningoencephalitis after streptokinase treatment. J. Neurol. Neurosurg. Psychiatry (2001) 70:132-133.
145. DUCHENE DA, SMITH CP, GOLDFARB RA: Allopurinol induced meningitis. J. Urol. (2000) 164:2028.
146. GREENBERG LE, NGUYEN T, MILLER SM: Suspected allopurinol-induced aseptic meningitis. Pharmacotherapy (2001) 21:1007-1009.
147. ISHIHARA O, OMATA T: A case of famotidine-induced aseptic meningitis. Rinsho Shinkeigaku (2000) 40:48-50.
148. BARBOT F, DANAN-CAUSANSKI S, CHAOUAT D, THUONG M: Aseptic meningitis after ranitidine treatment for systemic lupus erythematosus. Presse Med. (1999) 28:1938.
149. DURAND JM, SUCHET L, MORANGE S, MICHEL B: Ranitidine and aseptic meningitis. Br. Med. J. (1996) 312:886.
150. DANG CT, RILEY DK: Aseptic meningitis secondary to carbamazepine therapy. Clin. Infect. Dis. (1996) 22:729-730.
151. HILTON E, STROH EM: Aseptic meningitis associated with administration of carbamazepine. J. Infect. Dis. (1989) 159:363-364.
152. SIMON LT, HSU B, ADORNATO BT: Carbamazepine-induced aseptic meningitis. Ann. Intern. Med. (1990) 112:627-628.
153. HERLIHY TE: Phenazopyridine and aseptic meningitis. Ann. Intern. Med. (1987) 106:172-173.
154. LAFAURIE M, DIXMIER A, MOLINA JM: Aseptic meningitis associated with intravenous administration of dexchlorpheniramine. Ann. Med. Interne (Paris) (2003) 154:179-180.
155. OKAZAKI H, HATAKEYAMA M, MORI M, MINATO N, SUMIYA M, KANO S: A case of mixed connective tissue disease exacerbated by griseofulvin complicating aseptic meningo-encephalitis and disseminated intravascular coagulation. Ryumachi (1990) 30:418-425.
156. THILMANN AF, MOBIUS E, THILMANN RR, TOPPER R: Recurrent aseptic meningitis (Mollaret meningitis)-spontaneous and drug-induced origin. Fortschr. Neurol. Psychiatr. (1991) 59:493-497.
157. JOFFE AM, FARLEY JD, LINDEN D, GOLDSAND G: Trimethoprim-sulfamethoxazole-associated aseptic meningitis: case reports and review of the literature. Am. J. Med. (1989) 87:332-338.
158. JURADO R, CARPENTER SL, RIMLAND D: Case reports: trimethoprim-sulfamethoxazole-induced meningitis in patients with HIV infection. Am. J. Med. Sci (1996) 312:27-29.
159. CREEL GB, HURTT M: Cephalosporin-induced recurrent aseptic meningitis. Ann. Neurol. (1995) 37:815-817.
160. ANTONEN J, HULKKONEN J, PASTERNACK A, HURME M: Interleukin 6 may be an important mediator of trimethoprim-induced systemic adverse reaction resembling aseptic meningitis. Arch. Intern. Med. (2000) 160:2066-2067.
161. VAN GAMEREN MM, WILLEMSE PH, MULDER NH et al.: Effects of recombinant human interleukin-6 in cancer patients: a Phase I-II study. Blood (1994) 84:1434-1441.
162. NARANJO CA, BUSTO U, SELLERS EM et al.: A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. (1981) 30:239-245.
163. LEE RZ, HARDIMAN O, O'CONNELL PG: Ibuprofen-induced aseptic meningoencephalitis. Rheumatology (Oxford) (2002) 41:353-355.
164. HORN AC, JARRETT SW: Ibuprofen-induced aseptic meningitis in rheumatoid arthritis. Ann. Pharmacother. (1997) 31:1009-1011.
165. COLAMARINO R, SOUBRIER M, ZENUT-LEAUD M, PRUDAT M, TOURNILHAC M, BUSSIERE JL: Aseptic meningitis caused by ibuprofen (Nurofen) in connective tissue diseases. Therapie (1993) 48:516-518.
166. GRIMM AM, WOLF JE: Aseptic meningitis associated with nonprescription ibuprofen use. DICP (1989) 23:712.
167. GILBERT GJ, EICHENBAUM HW: Ibuprofen-induced meningitis in an elderly patient with systemic lupus erythematosus. South. Med. J. (1989) 82:514-515.
168. KATONA BG, WIGLEY FM, WALTERS JK, CASPI M: Aseptic meningitis from over-the-counter ibuprofen. Lancet (1988) 1:59.
169. QUINN JP, WEINSTEIN RA, CAPLAN LR: Eosinophilic meningitis and ibuprofen therapy. Neurology (1984) 34:108-109.
170. PECK MG, JOYNER PU: Ibuprofen-associated aseptic meningitis. Clin. Pharm. (1982) 1:561-565.
171. GIANSIRACUSA DF, BLUMBERG S, KANTROWITZ FG: Aseptic meningitis associated with ibuprofen. Arch. Intern. Med. (1980) 140:1553.
172. HIDALGO NA, CARDENAS CR, NAJEM RN, CANTO DG: [Ibuprofen, aseptic meningitis, systemic lupus erythematosus]. Med. Clin. (Barc) (2004) 122:678-679.
173. HANSON L: Ibuprofen-induced aseptic meningitis. J. Tenn. Med. Assoc. (1994) 87:58.
174. KAPLAN BH, NEVITT MP, PACH JM, HERMAN DC: Aseptic meningitis and iridocyclitis related to ibuprofen. Am. J. Ophthalmol. (1994) 117:119-120.
175. MANDELL BF, RAPS EC: Severe systemic hypersensitivity reaction to ibuprofen occurring after prolonged therapy. Am. J. Med. (1987) 82:817-820.
176. LAWSON JM, GRADY MJ: Ibuprofen-induced aseptic meningitis in a previously healthy patient. West J. Med. (1985) 143:386-387.
177. BERNSTEIN RF: Ibuprofen-related meningitis in mixed connective tissue disease. Ann. Intern. Med. (1980) 92:206-207.
178. RUPPERT GB, BARTH WF: Ibuprofen hypersensitivity in systemic lupus erythematosus. South. Med. J. (1981) 74:241-243.
179. BAR-SELA S, LEVO Y, ZEEVI D, SLAVIN S, ELIAKIM M: A lupus-like syndrome due to Ibuprofen hypersensitivity. J. Rheumatol. (1980) 7:379-380.
180. LEE RP, KING EG, RUSSELL AS: Ibuprofen: a severe systemic reaction. Can. Med. Assoc. J. (1983) 129:854-855.
181. PETERSON DI, BEN CHONG Y: Recurrent meningitis due to nonsteroidal anti-inflammatory drugs. Bull Clin. Neurosci. (1987) 52:40-42.
182. YASUDA Y, AKIGUCHI I, KAMEYAMA M: Sulindac-induced aseptic meningitis in mixed connective tissue disease. Clin. Neurol. Neurosurg. (1989) 91:257-260.
183. NEUFELD MY, KORCZYN AD: Encephalopathy associated with sulindac. Hum. Toxicol. (1986) 5:55.
184. SYLVIA LM, FORLENZA SW, BROCAVICH JM: Aseptic meningitis associated with naproxen. Drug Intell. Clin. Pharm. (1988) 22:399-401.
185. CHAZAN B, WEISS A, WEINER Z, RIMBROT S, RAZ R: Drug induced aseptic meningitis due to diclofenac. J. Neurol. (2003) 250:1503-1504.
186. ROEL JE, GADANO AC, FALCON JL: Ketoprofen and aseptic meningitis. Medicina (B Aires) (1991) 51:186.
187. NAIR J, STACY M: Aseptic meningitis associated with salicylate overdose. Psychosomatics (1993) 34:372.
188. PAPAIOANNIDES DH, KORANTZOPOULOS PG, GIOTIS CH: Aseptic meningitis possibly associated with celecoxib. Ann. Pharmacother. (2004) 38:172.
189. REDMAN RC, MILLER JB, HOOD M, DEMAIO J: Trimethoprim-induced aseptic meningitis in an adolescent male. Pediatrics (2002) 110:e26.
190. GILROY N, GOTTLIEB T, SPRING P, PEIRIS O: Trimethoprim-induced aseptic meningitis and uveitis. Lancet (1997) 350:112.
191. DE LA MONTE SM, HUTCHINS GM, GUPTA PK: Aseptic meningitis, trimethoprim, and Sjogren's syndrome. JAMA (1985) 253:2192.
192. SAHA H, LUMIO J, PASTERNACK A: Acute aseptic meningitis induced by trimethoprim. Duodecim (1988) 104:257-261.
193. MULLER MP, RICHARDSON DC, WALMSLEY SL: Trimethoprim-sulfamethoxazole induced aseptic meningitis in a renal transplant patient. Clin. Nephrol. (2001) 55:80-84.
194. MENG MV, ST LEZIN M: Trimethoprim-sulfamethoxazole induced recurrent aseptic meningitis. J. Urol. (2000) 164:1664-1665.
195. TONOLLI I, VELUT JG, LAFAY V, THOMACHOT L, GAMBINI D, FRANCES Y: Cotrimoxazole-induced aseptic meningitis: two cases. Presse Med. (1998) 27:716-717.
196. POLES L, THEODOR E: Trimethoprim-sulphamethoxazole-induced meningitis. Harefuah (1996) 130:817-819, 879.
197. CARRILLO F, CUBERO A, HERNANDEZ GJ, JIMENEZ SP: Recurrence of meningoencephalitis induced by cotrimoxazole. Rev. Neurol. (1995) 23:142-144.
198. WONG JG, HATHAWAY SC, PAAT JJ, PATERSON RW, STEELE GH, JR: Drug-induced meningitis. A case involving trimethoprim-sulfamethoxazole. Postgrad. Med. (1994) 96:117-124.
199. ESCALANTE A, STIMMLER MM: Trimethoprim-sulfamethoxasole induced meningitis in systemic lupus erythematosus. J. Rheumatol. (1992) 19:800-802.
200. TUNKEL AR, STARR K: Trimethoprim-sulfamethoxazole-associated aseptic meningitis. Am. J. Med. (1990) 88:696-697.
201. GORDON MF, ALLON M, COYLE PK: Drug-induced meningitis. Neurology (1990) 40:163-164.
202. CARLSON J, WIHOLM BE: Trimethoprim associated aseptic meningitis. Scand J. Infect. Dis. (1987) 19:687-691.
203. STREIFFER RH, HUDSON JG: Aseptic meningitis and trimethoprim-sulfamethoxazole. J. Fam. Pract. (1986) 23:314.
204. KREMER I, RITZ R, BRUNNER F: Aseptic meningitis as an adverse effect of co-trimoxazole. N. Engl. J. Med. (1983) 308:1481.
205. ANDRADE A, HILMAS E, WALTER C: A rare occurrence of trimethoprim/sulfamethoxazole (TMP/SMX)-induced aseptic meningitis in an older woman. J. Am. Geriatr. Soc. (2000) 48:1537-1538
206. RUDY BJ, RUTSTEIN R: Aseptic meningitis from trimethoprim-sulfamethoxazole in an HIV-infected adolescent. Pediatr. Emerg. Care (1997) 13:216-217.
207. PASHANKAR D, MCARDLE M, ROBINSON A: Co-trimoxazole induced aseptic meningitis. Arch. Dis. Child. (1995) 73:257-58.
208. AUXIER GG: Aseptic meningitis associated with administration of trimethoprim and sulfamethoxazole. Am. J. Dis. Child (1990) 144:144-145.
209. BIOSCA M, DE LA FM, GARCIA-BRAGADO F, SAMPOL G: Aseptic meningitis due to trimethoprim-sulfamethoxazole. J. Neurol. Neurosurg. Psychiatry (1986) 49:332-33.
210. HAAS EJ: Trimethoprim-sulfamethoxazole: another cause of recurrent meningitis. JAMA (1984) 252:346.
211. THERRIEN R: Possible Trimethoprim/Sulfamethoxazole-Induced Aseptic Meningitis (November). Ann. Pharmacother. (2004)
212. CORSON AP, CHRETIEN JH: Metronidazole-associated aseptic meningitis. Clin. Infect. Dis. (1994) 19:974.
213. SUNDSTROM O, SVEDBERG LE, CARLING L: Meningitis caused by metronidazole. Lakartidningen (1984) 81:3480.
214. ASPERILLA MO, SMEGO RA, JR: Eosinophilic meningitis associated with ciprofloxacin. Am. J. Med. (1989) 87:589-590.
215. BODOKH I, LACOUR JP, COSTA I, BOTCAZOU V, CHICHMANIAN RM, ORTONNE JP: Aseptic meningitis during pyrazinamide therapy for lupus erythematosus. Presse Med. (1993) 22:595-596.
216. MONDON M, OLLIVIER L, DAUMONT A: Aseptic meningitis ornidazole-induced in the course of infectious endocarditis. Rev. Med. Interne (2002) 23:784-787.